Clinical Trials Logo

Addiction clinical trials

View clinical trials related to Addiction.

Filter by:

NCT ID: NCT04587115 Completed - Addiction Clinical Trials

Reducing the Abuse Liability of Prescription Opioids

Start date: June 16, 2017
Phase: Early Phase 1
Study type: Interventional

Opioid (commonly called narcotic) pain medicines are, after marijuana, the most commonly abused substances in the United States. Patients who take opioids for legitimate reasons may become addicted; for example, as many as 1 in 4 patients meet the criteria for current opioid dependence. It is very important that a way is found to provide pain relief while minimizing the addiction potential of these widely used pain medications. The study aim to find out if the use of another type of medication given in addition to an opioid will reduce the addiction potential of the opioid. The study is trying to find out if the ability of the opioid to relieve pain is changed when given with the other medication, and to see if the euphoric sensation or "liking" of the opioid pain medication is reduced when taken with the other medication.

NCT ID: NCT04458181 Completed - Addiction Clinical Trials

Journaling and Addiction Recovery: Piloting "Positive Recovery Journaling"

PPJ
Start date: July 7, 2020
Phase: N/A
Study type: Interventional

The main objective of this study is to pilot test the Positive Peer Journaling (PPJ) [later renamed "Positive Recovery Journaling" (PRJ)] intervention and its feasibility and acceptability. A second objective is to compare individuals assigned to PPJ to individuals in a treatment as usual control group.

NCT ID: NCT04409106 Completed - Addiction Clinical Trials

The Turkish Version of the Parental Smartphone Use Management Scale (PSUMS)

Start date: September 10, 2020
Phase:
Study type: Observational

Parental Smartphone Use Management Scale (PSUMS) was originally developed in English language to parents to educate adolescents and communicate with them about online behavior and safety, as well as to conduct plans to manage adolescents' internet and smartphone use. The purpose of this study was to translate and cross-culturally adapt the PSUMS.

NCT ID: NCT04337775 Completed - Healthy Clinical Trials

The Turkish Version of the Smartphone Impact Scale

Start date: May 7, 2020
Phase:
Study type: Observational

Smartphone Impact Scale (SIS) was originally developed in English to determine the cognitive, affective, social, and behavioral impacts of smartphones in everyday life. The purpose of this study was to translate and cross-culturally adapt the SIS instrument into Turkish and investigate its psychometric properties.

NCT ID: NCT04292197 Completed - Addiction Clinical Trials

A Study to Assess 18-Methoxycoronaridine (18-MC HCl) in Healthy Volunteers

Start date: April 14, 2020
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to assess the safety and tolerability of a single day dosing and a separate multiple day dosing of 18-MC HCl administered orally, each part of the study having a different set of healthy male and female volunteers.

NCT ID: NCT04159571 Completed - Smoking Cessation Clinical Trials

QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt

Start date: August 20, 2020
Phase: N/A
Study type: Interventional

Cigarette smoking constitutes the greatest preventable cause of mortality and morbidity in the US. The most critical period for long term success of smoking cessation appears to be in the first 7 days after the quit date. A metaanalysis of 3 pharmacotherapy trials revealed that abstinence during the first 7 days was the strongest predictor of 6 month outcomes (n=1649; Odds ratio: 1.4, P <0.0001; Ashare et al. 2013). Prodigious relapse rates during this first week of smoking cessation are likely due to behavioral and neurobiological factors that contribute to high cue-associated craving and low executive control over smoking. The long term goal of the research is to develop evidence-based transcranial magnetic stimulation protocols to facilitate abstinence during this critical period.

NCT ID: NCT04133688 Completed - Addiction Clinical Trials

Mobile App in Addiction

ASC-Val
Start date: October 30, 2019
Phase: N/A
Study type: Interventional

The sleep and behavior agendas are today very largely underused while they can be of a considerable contribution in the follow-up of the patients and the reinforcement of the therapeutic alliance. In the management of addictions, sleep disorders are a major comorbidity, these two components maintain indeed complex links: it was highlighted a bidirectional relationship between the effect of the consumption of addictive substances on sleep and conversely, the effect of sleep disorders on the consumption of products, the same is true for overexposure to screens.

NCT ID: NCT04110626 Completed - Addiction Clinical Trials

Realistic Evaluation of Expériences Animées, a School-based Intervention in Nouvelle Aquitaine

ERIEAS
Start date: September 30, 2019
Phase:
Study type: Observational

The study is a realistic evaluation of the Expériences Animées school-based programme. The aim is to precisely characterize i) the effects in terms of alcohol and cannabis consumption, the use of health professionals in case of problematic use of those two substances; ii) the context and underpinning mechanisms triggered by the program in terms of changes of alcohol and cannabis representations and life skills development. This evaluation could allow to produce the key functions of the programme: how the intervention works, in which conditions.

NCT ID: NCT04099173 Completed - Suicidal Ideation Clinical Trials

A Brief Mindfulness-Based Intervention for Suicidal Ideation

MB-SI
Start date: September 1, 2019
Phase: N/A
Study type: Interventional

The primary aim of this study is to determine whether a Brief Mindfulness-Based Intervention for Suicidal Ideation (MB-SI) is feasible and safe to implement. The secondary aims are short and longer-term reduction in suicidal ideation (SI) and/or suicide-related behaviors (SRBs) as well as improvements in mindfulness and emotional regulation measures compared to Treatment as Usual (TAU).

NCT ID: NCT03903159 Completed - Addiction Clinical Trials

Piloting "Positive Peer Journaling" a Journaling Practice to Support Recovery From Addiction

PPJ
Start date: January 29, 2019
Phase: N/A
Study type: Interventional

The main objective of this study is development of the Positive Peer Journaling (PPJ) intervention and the feasibility, acceptability, and logistics of treatment delivery. A second objective is to observe whether PPJ is associated with improvement in hypothesized outcomes. The primary outcomes the investigators will examine are enhanced treatment retention and reduced recurrence of substance use. The investigators will also explore the association between the intervention and a set of hypothesized mediators of the effect of the intervention on outcomes, e.g., improvement in mood and satisfaction with recovery.